{
    "clinical_study": {
        "@rank": "33523", 
        "arm_group": [
            {
                "arm_group_label": "Propafenone", 
                "arm_group_type": "Active Comparator", 
                "description": "Propafenone group"
            }, 
            {
                "arm_group_label": "Dronedarone", 
                "arm_group_type": "Active Comparator", 
                "description": "Dronedarone group"
            }
        ], 
        "brief_summary": {
            "textblock": "the purpose of this study is to compare the ability of propafenone and dronedarone to\n      maintain sinus rhythm after DC cardioversion"
        }, 
        "brief_title": "Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "detailed_description": {
            "textblock": "Atrial fibrillation is the most common arrhythmia requiring continuous therapy. Conversion\n      to and maintenance of sinus rhythm is important. Propafenone and dronedarone has been used\n      as treatment for maintenance of sinus rhythm after DC cardioversion. But there are no direct\n      comparison study.\n\n      The purpose of this study is to compare the ability of propafenone and dronedarone to\n      maintain sinus rhythm after DC cardioversion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  a patient with persistent atrial fibrillation who received successful DC\n             cardioversion\n\n        Exclusion Criteria:\n\n          -  prior amiodarone use\n\n          -  NYHA class III or IV heart failure\n\n          -  Left ventricular ejection fraction < 35%\n\n          -  second or third AV block\n\n          -  sick sinus syndrome\n\n          -  heart rate < 50 beat per minute\n\n          -  myocardiac infarction within 3 months\n\n          -  pregnant women\n\n          -  severe hepatic dysfunction\n\n          -  QT prolongation > 500ms or PR interval > 180ms\n\n          -  history of hypersensitivity for drug"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "98", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01991119", 
            "org_study_id": "2011-03-085-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Propafenone", 
                "intervention_name": "Propafenone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Dronedarone", 
                "intervention_name": "Dronedarone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Propafenone", 
                "Amiodarone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Atrial fibrillation", 
            "Propafenone", 
            "Dronedarone"
        ], 
        "lastchanged_date": "November 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "135-710"
                }, 
                "name": "Cardiac and Vascular Center"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation After DC Cardioversion", 
        "overall_official": {
            "affiliation": "Samsung Medical Center", 
            "last_name": "Young Keun On, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "recurrence of atrial fibrillation", 
            "safety_issue": "No", 
            "time_frame": "6 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01991119"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Samsung Medical Center", 
            "investigator_full_name": "Young Keun On", 
            "investigator_title": "Principle investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Samsung Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Samsung Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}